PCV44 Real-World Assessment of the Use of Anti-platelet Therapy for Recurrent Stroke Prevention in US Patients without Atrial Fibrillation with Recent Ischemic Stroke or Transient Ischemic Attack

This study evaluated current AP treatment patterns in a real-world setting following an initial ischemic stroke (IS) or transient ischemic attack (TIA).

Source: Value in Health - June 1, 2021 Category: International Medicine & Public Health Authors: E. O'Brien, D. Milentijevic, R. Roychowdhury, S. Mitra, Y.W. Chen Source Type: research